Annals of Neurology · 2014 · 103 citations · 37 references
MedicineNeurologyNeuroscienceDementiaDiagnostic ImagingNeuropsychiatryBrain ImagingDementia BiomarkersDiffusion ImagingFrontotemporal DementiaNeurodegenerative DiseasesNeurodegenerative DisordersDiffusion Magnetic Resonance ImagingDiffusion Tensor Imaging MarkersDiffusivityFractional AnisotropyMean DiffusivityNeuropsychological BatteriesNeuropsychological Test BatteriesWhite Matter Microstructure
OBJECTIVE: Novel biomarkers for monitoring progression in neurodegenerative conditions are needed. Measurement of microstructural changes in white matter (WM) using diffusion tensor imaging (DTI) may be a useful outcome measure. Here we report trajectories of WM change using serial DTI in a cohort with behavioral variant frontotemporal dementia (bvFTD). METHODS: Twenty-three patients with bvFTD (12 having genetic mutations), and 18 age-matched control participants were assessed using DTI and neuropsychological batteries at baseline and ~1.3 years later. Baseline and follow-up DTI scans were registered using a groupwise approach. Annualized rates of change for DTI metrics, neuropsychological measures, and whole brain volume were calculated. DTI metric performances were compared, and sample sizes for potential clinical trials were calculated. RESULTS: In the bvFTD group as a whole, rates of change in fractional anisotropy (FA) and mean diffusivity (MD) within the right paracallosal cingulum were greatest (FA: -6.8%/yr, p < 0.001; MD: 2.9%/yr, p = 0.01). MAPT carriers had the greatest change within left uncinate fasciculus (FA: -7.9%/yr, p < 0.001; MD: 10.9%/yr, p < 0.001); sporadic bvFTD and C9ORF72 carriers had the greatest change within right paracallosal cingulum (sporadic bvFTD, FA: -6.7%/yr, p < 0.001; MD: 3.8%/yr, p = 0.001; C9ORF72, FA: -6.8%/yr, p = 0.004). Sample size estimates using FA change were substantially lower than neuropsychological or whole brain measures of change. INTERPRETATION: Serial DTI scans may be useful for measuring disease progression in bvFTD, with particular trajectories of WM damage emerging. Sample size calculations suggest that longitudinal DTI may be a useful biomarker in future clinical trials.
37
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Katya Rascovsky, John R. Hodges, David S. Knopman et al. · Brain · 2011 · 5.3K citations · Full text
Medicine, Neurology, Psychiatry +17
Britt Appelhof, Christian Bakker, Jeannette C.L. van Duinen‐van den IJssel et al. · Dementia and Geriatric Cognitive Disorders · 2017 · 2.8K citations · Full text
Neurodegenerative Diseases Target Large-Scale Human Brain Networks
William W. Seeley, Richard K. Crawford, Juan Zhou et al. · Neuron · 2009 · 2.4K citations · Full text
Predicting Regional Neurodegeneration from the Healthy Brain Functional Connectome
Juan Zhou, Efstathios D. Gennatas, Joel H. Kramer et al. · Neuron · 2012 · 720 citations · Full text